Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
Interview with Asya Chernyavskaya
Read the short interview with Asya Chernyavskaya, Executive Director in Microbiological Center, Akrikhin, Russia.
What were the areas where you have faced risks and had to mitigate them? What were the steps you had to undergo?
It's important to manage risks in all areas and stages related to the quality of a drug: R&D, assessment of a design for a warehouse/quality control laboratory, assessment of necessity for implementing changes, investigation of deviations, evaluation of suppliers, etc.The process of risk management includes the task of taking accurate (maybe at times risky, but conscious and well-balanced) decisions. The outcome of the risk management process: confidence in stable and predictable manufacturing processes.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.